Atlas Trials

Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)

Clinical trial NCT04432324 · COMPLETED

Trial details

NCT number
NCT04432324
Sponsor
Instituto Grifols, S.A.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-06-02
Primary completion
2021-03-03
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.